Assessment of robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect

N Horesh, D Bomze, C Lim, G Markel, T Meirson, D Azoulay

Research output: Contribution to journalReview articlepeer-review

Original languageAmerican English
Number of pages10
JournalHepatobiliary Surgery and Nutrition
StatePublished - 9 Jul 2021


  • Cholangiocarcinoma (CC)
  • Randomized controlled trials
  • Restricted mean survival time (RMST)
  • Robustness of evidence
  • Spin effect
  • Survival-inferred fragility index (SIFI)

Cite this